- Source: Pemafibrate
Pemafibrate, sold under the brand namd Parmodia, is a peroxisome proliferator-activated receptor alpha (PPARĪ±) agonist. It is developed and marketed by Kowa Pharmaceuticals.
In July 2017, Pharmaceuticals and Medical Devices Agency approved it in Japan.
References
Kata Kunci Pencarian:
- Pemafibrate
- ATC code C10
- Ibuprofen
- Fibrate
- GW501516
- Thiazolidinedione
- Fenofibrate
- Perfluorooctanoic acid
- Pioglitazone
- Troglitazone
